SA202
CEBe018-A
General
Cell Line |
|
hPSCreg name | CEBe018-A |
Cite as: | CEBe018-A (RRID:CVCL_B302) |
Alternative name(s) |
SA202
|
Cell line type | Human embryonic stem cell (hESC) |
Similar lines | No similar lines found. |
Last update | 3rd September 2022 |
User feedback | |
Provider |
|
Generator |
Takara Bio Europe AB (former Cellartis) (CEB)
Contact:
Human ES cell line derivation |
Derivation country | Sweden |
External Databases |
|
Cellosaurus | CVCL_B302 |
Wikidata | Q54952010 |
General Information |
|
Publications |
|
Projects | |
* Is the cell line readily obtainable for third parties? |
Yes |
Donor Information
General Donor Information |
|
Phenotype and Disease related information (Donor) |
|
Diseases |
Ethics
Alternatives to consent are available? | Yes |
Alternatives to consent | |
Alternative consent approval number | |
How may genetic information associated with the cell line be accessed? |
hESC Derivation
Date of derivation | 2002-11-01 |
Embryo stage | Blastula with ICM and Trophoblast |
PGD Embryo? |
No |
ZP removal technique | Enzymatic |
Cell isolation | Immunosurgery |
Cell seeding | Isolated ICM |
Culture Conditions
Surface coating | MEF | |||||||||
Medium |
Other medium:
Base medium: DMEM/F12 with Glutamax
Main protein source: Anti-Human-Serum(Sigma) Serum concentration: % Supplements
|
Characterisation
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
Alkaline Phosphatase |
Yes |
|
||||
SSEA-3 |
Yes |
|
||||
SSEA-4 |
Yes |
|
||||
TRA 1-60 |
Yes |
|
||||
TRA 1-81 |
Yes |
|
||||
SSEA-1 |
No |
|
||||
NANOG |
Yes |
|
||||
POU5F1 (OCT-4) |
Yes |
|
Differentiation Potency
Genotyping
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Yes
46XY
Passage number: 18
|
Other Genotyping (Cell Line) |
Login to share your feedback, experiences or results with the research community.